These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1694908)

  • 41. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study.
    Baart de la Faille H; van Weelden H; Banga JD; van Kesteren RG
    Arch Dermatol Res; 1986; 279(1):3-7. PubMed ID: 3545103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-response study of prazosin in Raynaud's phenomenon: clinical effectiveness versus side effects.
    Wollersheim H; Thien T
    J Clin Pharmacol; 1988 Dec; 28(12):1089-93. PubMed ID: 3243924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA; Malamet R; Wigley FM
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digital and radial artery blood flow in patients with Raynaud's phenomenon in response to nifedipine.
    Morgan RH; Psaila JV; Davies WT; Carolan G; Woodcock JP
    Eur J Vasc Surg; 1987 Dec; 1(6):403-8. PubMed ID: 3503035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of ketanserin in the therapy of Raynaud's phenomenon: thermometric data.
    Arosio E; Montesi G; Zannoni M; Perbellini L; Paluani F; Lechi A
    Angiology; 1991 May; 42(5):408-13. PubMed ID: 2035893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ketanserin on peripheral blood flow, haemorheology, and platelet function in patients with Raynaud's phenomenon.
    Longstaff J; Gush R; Williams EH; Jayson MI
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S99-101. PubMed ID: 2412071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 49. Regional intravenous ketanserin and guanethidine therapy in Raynaud's phenomenon.
    Caputi CA; De Carolis G; Tomasetti C
    Angiology; 1991 Jun; 42(6):473-80. PubMed ID: 2042796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
    Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
    J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
    Cristol R; Graisely B; Cloarec M; Debray J
    Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcutaneous electrical nerve stimulation (TENS) in Raynaud's phenomenon.
    Mulder P; Dompeling EC; van Slochteren-van der Boor JC; Kuipers WD; Smit AJ
    Angiology; 1991 May; 42(5):414-7. PubMed ID: 2035894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon.
    Freedman RR; Mayes MD; Sabharwal SC
    Circulation; 1989 Oct; 80(4):859-62. PubMed ID: 2791249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
    Gross R; Galus K; Zajac S; Jedrasik M
    Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind, placebo-controlled study of prazosin in Raynaud's phenomenon.
    Wollersheim H; Thien T; Fennis J; van Elteren P; van 't Laar A
    Clin Pharmacol Ther; 1986 Aug; 40(2):219-25. PubMed ID: 3731684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total and capillary fingertip blood flow in Raynaud's phenomenon.
    Coffman JD; Cohen AS
    N Engl J Med; 1971 Jul; 285(5):259-63. PubMed ID: 5090397
    [No Abstract]   [Full Text] [Related]  

  • 58. Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
    Freedman RR; Moten M; Migály P; Mayes M
    Arthritis Rheum; 1993 May; 36(5):685-90. PubMed ID: 8387786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
    DiGiacomo RA; Kremer JM; Shah DM
    Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digital cutaneous vascular responses to histamine and neuropeptides in Raynaud's phenomenon.
    Bunker CB; Foreman JC; Dowd PM
    J Invest Dermatol; 1991 Mar; 96(3):314-7. PubMed ID: 2002251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.